Trials / Completed
CompletedNCT00033033
Reserpine for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo-Controlled Trial of Reserpine for the Treatment of Cocaine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.
Detailed description
To assess the efficacy and safety of reserpine in reducing cocaine use in subjects with cocaine dependence. This is a double-blind, placebo-controlled, parallel-group design with a 2 week baseline period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Reserpine |
Timeline
- Start date
- 2001-07-01
- Completion
- 2003-05-01
- First posted
- 2002-04-08
- Last updated
- 2017-01-12
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00033033. Inclusion in this directory is not an endorsement.